We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$238M
AUM Growth
+$3.32M
Cap. Flow
-$2.31M
Cap. Flow %
-0.97%
Top 10 Hldgs %
40.65%
Holding
138
New
3
Increased
34
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
CTMX icon
CytomX Therapeutics
CTMX
+$1.42M
2
PSLV icon
Sprott Physical Silver Trust
PSLV
+$566K
3
Q
Qnity Electronics Inc
Q
+$357K
4
CB icon
Chubb
CB
+$189K
5
WU icon
Western Union
WU
+$148K

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$2.1M
2
PYXS icon
Pyxis Oncology
PYXS
+$611K
3
DD icon
DuPont de Nemours
DD
+$452K
4
SLV icon
iShares Silver Trust
SLV
+$441K
5
CTAS icon
Cintas
CTAS
+$290K

Sector Composition

Rank Sector Weight
1 Financials 21.72%
2 Consumer Staples 17.43%
3 Industrials 12.82%
4 Healthcare 12.68%
5 Technology 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
101
Visa
V
$694B
$316K 0.13%
900
– –
DIA icon
102
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45B
$315K 0.13%
655
– –
UNM icon
103
Unum
UNM
$14.3B
$310K 0.13%
4,000
– –
SPY icon
104
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$307K 0.13%
450
– –
ITW icon
105
Illinois Tool Works
ITW
$81.4B
$306K 0.13%
1,242
– –
AEP icon
106
American Electric Power
AEP
$72.4B
$299K 0.13%
2,595
– –
WDFC icon
107
WD-40
WDFC
$3.44B
$297K 0.13%
1,510
– –
SOLV icon
108
Solventum
SOLV
$14.1B
$295K 0.12%
3,726
-149
-4% -$11.4K
WU icon
109
Western Union
WU
$2.61B
$295K 0.12%
31,650
+16,800
+113% +$148K
KMI icon
110
Kinder Morgan
KMI
$72.4B
$286K 0.12%
10,411
– –
AMGN icon
111
Amgen
AMGN
$201B
$284K 0.12%
869
– –
BA icon
112
Boeing
BA
$169B
$284K 0.12%
1,310
– –
LAMR icon
113
Lamar Advertising Co
LAMR
$16.5B
$278K 0.12%
2,195
– –
SJM icon
114
J.M. Smucker
SJM
$12.2B
$268K 0.11%
2,741
-630
-19% -$65.1K
MAC icon
115
Macerich
MAC
$7.32B
$255K 0.11%
13,801
– –
CLX icon
116
Clorox
CLX
$11.9B
$249K 0.1%
2,468
– –
EW icon
117
Edwards Lifesciences
EW
$50.6B
$243K 0.1%
2,856
– –
KVUE icon
118
Kenvue
KVUE
$36.5B
$241K 0.1%
13,978
-1,595
-10% -$26.1K
SHW icon
119
Sherwin-Williams
SHW
$83.4B
$238K 0.1%
736
– –
COP icon
120
ConocoPhillips
COP
$137B
$224K 0.09%
2,398
– –
TGNA
121
DELISTED
TEGNA Inc
TGNA
$215K 0.09%
11,100
-2,000
-15% -$39.5K
HD icon
122
Home Depot
HD
$347B
$202K 0.09%
587
+1
+0.2% +$366
CB icon
123
Chubb
CB
$133B
$202K 0.09%
+647
New +$189K
ASRV icon
124
AmeriServ Financial
ASRV
$66M
$41.5K 0.02%
13,000
– –
AVDL
125
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-137,500
Closed -$2.1M
2 3 4
5
6

Similar funds

HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
YP
YANKCOM Partnership Yankton, South Dakota $243M AUM 21.59% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return

Schulhoff & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Schulhoff & Co held 138 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schulhoff & Co's Q4 2025 filing shows 3 new, 34 increased, 36 reduced and 6 closed positions. Its largest new stake was CytomX Therapeutics: 374,850 shares worth $1.6M. The largest sale was Avadel Pharmaceuticals, an estimated $2.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Industrials.

  • Schulhoff & Co's largest Q4 2025 buy was CytomX Therapeutics: 374,850 shares worth $1.6M.
  • Schulhoff & Co added most to Sprott Physical Silver Trust in Q4 2025, an estimated $566K increase.
  • Schulhoff & Co's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $452K.
  • Schulhoff & Co fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $2.1M.
  • Schulhoff & Co's ten largest holdings make up 41% of its $238M portfolio in Q4 2025.
  • Schulhoff & Co opened 3 new positions and closed 6 in Q4 2025.
  • Schulhoff & Co's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.